A sialoadenectomy is associated with an increased risk of coronary heart disease: A three-year follow-up study

Shih-Han Hung1,2, Chin-Hui Su3, Herng-Ching Lin4

  • 1Department of Otolaryngology, Taipei Medical University Hospital, Taipei, Taiwan.

Plos One
|June 19, 2018
PubMed

Insights

Surgical removal of salivary glands (sialoadenectomy) may increase the risk of developing coronary heart disease (CHD). This study found a 2.43 times higher hazard ratio for CHD in patients who underwent sialoadenectomy.

Area of Science:

  • Cardiology
  • Surgical Oncology
  • Epidemiology

Background:

  • Long-term adverse effects of sialoadenectomy are not well-documented.
  • Sialoadenectomy involves the surgical removal of salivary glands.
  • Understanding post-surgical risks is crucial for patient care.

Purpose of the Study:

  • To investigate the association between sialoadenectomy and the risk of coronary heart disease (CHD).
  • To estimate the long-term risk of CHD following sialoadenectomy.

Main Methods:

  • Retrospective cohort study using Taiwan's Longitudinal Health Insurance Database 2005.
  • Included 608 patients who underwent sialoadenectomy and 1824 propensity score-matched controls.
  • Followed patients for 3 years to identify CHD diagnoses.

Main Results:

  • Incidence rates of CHD were 3.87 per 100 person-years for sialoadenectomy patients vs. 1.79 for controls.
  • Sialoadenectomy was associated with a hazard ratio of 2.43 for CHD.
  • A statistically significant association was observed between sialoadenectomy and increased CHD risk.

Conclusions:

  • Sialoadenectomy is associated with an increased risk of developing coronary heart disease.
  • Further research is needed to elucidate the mechanisms behind this association.
  • This finding highlights potential long-term cardiovascular implications of sialoadenectomy.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
504
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
635
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
292
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
541
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
404